NEW YORK (GenomeWeb News) – Medical Solutions, a Nottingham, UK-based provider of DNA sequencing and genotyping services, this week announced that it has purchased Illumina’s next-generation sequencing instrument, the Genome Analyzer, and its BeadStation for whole-genome genotyping.
 
According to the firm, it is the first commercial service provider of those platforms in the UK.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.